Health Management Announces Fourth Quarter and Year-End 2012 Results

Health Management Announces Fourth Quarter and Year-End 2012 Results

Diluted EPS from Continuing Operations for the Fourth Quarter Ended December 31, 2012 Increased to $0.19

NAPLES, Fla.--(BUSINESS WIRE)-- Health Management Associates, Inc. (NYSE: HMA) today announced its consolidated financial results for the fourth quarter and year ended December 31, 2012.

Key metrics from continuing operations for the fourth quarter (all percentage changes in the bullet points below compare the fourth quarter of 2012 to the fourth quarter of 2011) include:

• As shown in the tables accompanying this press release, diluted earnings per share ("EPS") from continuing operations increased to $0.19. Excluding the impact of approximately $20.3 million, or $0.05 per diluted share, of interest rate swap accounting and mark-to-market adjustments on the swap due to interest rate conditions, and excluding approximately $52.6 million, or $0.12 per diluted share, of Medicare and Medicaid Healthcare Information Technology ("HCIT") incentive payments, net of Medicaid rate adjustments, diluted earnings per share from continuing operations was $0.12 per diluted share, as compared to $0.13 per diluted share in the prior year. Also impacting the fourth quarter was approximately $0.04 per diluted share of incremental legal and investigation expense and approximately $0.02 to $0.03 per diluted share related to Mississippi Medicaid payment reductions, which were offset by Medicare and Medicaid HCIT incentive payments;

• Net revenue increased 6.6% to $1.481 billion;

• Adjusted EBITDA increased 13.7% to $254.0 million;

• Same hospital net revenue increased 5.1% to $1.459 billion;

• Same hospital net revenue per adjusted admission increased 5.2%;

• As shown in the accompanying table, same hospital Adjusted EBITDA increased 22.2% to $324.9 million, resulting in a 320 basis point improvement in margin to 22.3%. Excluding HCIT incentive payments of approximately $52.6 million and $38.2 million for the fourth quarter 2012 and 2011, net of Medicaid rate adjustments, respectively, same hospital Adjusted EBITDA increased 19.6% to $272.3 million and same hospital Adjusted EBITDA margin increased 230 basis points to 18.7%; and

• Same hospital surgeries and emergency room visits increased 0.9% and 9.2%, respectively.

The tables accompanying this press release include reconciliations of consolidated net income to all presentations of Adjusted EBITDA (which is not a GAAP measure) contained in this press release. Those tables also reconcile earnings per share on a GAAP basis to those amounts presented in this press release and contain disclaimers and other important information regarding how Health Management defines and uses Adjusted EBITDA.

The continuing effects of a sluggish economy combined with declines in uninsured admissions and increases in observation stays contributed to a 4.7% decline in fourth quarter same hospital admissions and essentially flat same hospital adjusted admissions.

"Our 2012 results reflect both a challenging and successful fourth quarter and year. I am very proud of and thankful for the efforts of our physicians, nurses and health care professionals, whose hard work and dedication to delivering the best possible care are the reasons for our success," said Gary D. Newsome, Health Management's President and Chief Executive Officer. "While we are pleased with the overall results, we also recognize that there are always areas and processes that can be improved. As such, we will continue to focus on our patient-centered approach, cost management and partnership opportunities, while taking important strategic steps we believe will better position Health Management for continued success going forward."

For the fourth quarter, Health Management's provision for doubtful accounts was $234.6 million, or 13.7% of net revenue before the provision for doubtful accounts, compared to $195.1 million, or 12.3% of net revenue before the provision of doubtful accounts, for the same quarter a year ago.

Uninsured self-pay patient discounts for the fourth quarter were $334.0 million, compared to $254.5 million for the same quarter a year ago. Charity/indigent care write-offs were $28.4 million for the fourth quarter, compared to $23.1 million for the same quarter a year ago.

The sum of uninsured discounts, charity/indigent write-offs and the provision for doubtful accounts, as a percent of the sum of net revenue before the provision for doubtful accounts, uninsured discounts and charity/indigent write-offs (which Health Management refers to as its Uncompensated Patient Care Percentage) was 28.7% for the fourth quarter, compared to 25.4% for the fourth quarter a year ago, and 29.0% for the quarter ended September 30, 2012. Health Management believes that its Uncompensated Patient Care Percentage provides key information regarding the aggregate level of patient care for which it does not receive payment.

Cash flow from continuing operating activities for the fourth quarter was $139.2 million, after cash interest and cash tax payments aggregating $99.7 million. Days sales outstanding, or DSO, saw a one day improvement to 50 days as of December 31, 2012 compared to 51 days as of December 31, 2011. At December 31, 2012, Health Management's total leverage ratio was 3.54 and interest coverage ratio was 4.36, both ratios being well within its debt covenant requirements.

For the year ended December 31, 2012, Health Management reported a 15.5% growth in net revenue to $5.878 billion and a 16.6% increase in Adjusted EBITDA to $963.2 million, as shown in the accompanying table. Excluding approximately $71.2 million and $40.0 million of HCIT incentive payments, net of Medicaid rate adjustments, for 2012 and 2011 respectively, Adjusted EBITDA increased 13.5% to $892.0 million. As shown in the tables accompanying this press release, excluding the impact of approximately $103.2 million, or $0.25 per diluted share, for interest rate swap accounting and mark-to-market adjustments on the swap due to interest rate conditions, and the impact of approximately $71.2 million, or $0.17 per diluted share, of HCIT incentive payments, net of Medicaid rate adjustments, for the year ended December 31, 2012, diluted earnings per share from continuing operations increased 5.6% to $0.75 as compared to $0.71 per diluted share for the year ended December 31, 2011. Consolidated diluted earnings per share from continuing operations were $0.67 for the year ended December 31, 2012.

Health Management hospitals recognized $60.3 million and $92.0 million of HCIT incentive payments in the three months and year ended December 31, 2012, respectively, and $38.2 million and $40.0 million of HCIT incentive payments for the three months and year ended December 31, 2011, respectively. Health Management expects to recognize approximately $75.0 to $85.0 million of HCIT incentive payments during the year ending December 31, 2013.

As previously announced on February 6, 2013, a Health Management subsidiary has executed a definitive agreement to partner with the 480-bed Bayfront Health System, located in St. Petersburg, Florida. As part of the joint venture, Health Management will acquire an 80% interest in Bayfront Health System, and introduce an affiliation with ShandsHealthCare, part of UF&Shands, the University of Florida Academic Health Center. The total purchase price for our 80% interest will be approximately $162 million, plus a working capital adjustment. The transaction is subject to the execution of a lease agreement between the partnership and the City of St. Petersburg, as well as customary regulatory approvals.

Health Management's executive team will hold a conference call and webcast to discuss the contents of this press release and Health Management's consolidated financial results for the three months and year ended December 31, 2012 on Friday, February 15, 2013 at 11:00 a.m. ET. Investors are invited to access the webcast via Health Management's website at www.HMA.com or via www.streetevents.com. Alternatively, investors may join the conference call by dialing 877-476-3476.

Health Management will archive a copy of the audio webcast of the conference call, along with any related information that Health Management may be required to provide pursuant to Securities and Exchange Commission rules, on its website under the heading "Investor Relations" for a period of 60 days following the conference call and webcast.

Health Management enables America's best local health care by providing the people, processes, capital and expertise necessary for its hospital and physician partners to fulfill their local missions of delivering superior health care services. Upon completion of the previously announced transaction to joint venture the 480-bed Bayfront Health System, Health Management, through its subsidiaries, will operate 71 hospitals with approximately 11,000 licensed beds in non-urban communities located throughout the United States.

All references to "Health Management," "HMA" or the "Company" used in this release refer to Health Management Associates, Inc. and its affiliates.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects," "estimates," "projects," "anticipates," "believes," "intends," "plans," "may," "continues," "should," "could" and other similar words. All statements addressing operating performance, events or developments that Health Management Associates, Inc. expects or anticipates will occur in the future, including but not limited to incurrence of indebtedness, projections of revenue, income or loss, capital expenditures, earnings per share, debt structure, the provision for doubtful accounts, capital structure, repayment of indebtedness, the amount and timing of HCIT incentive payments, other financial items and operating statistics, statements regarding the plans and objectives of management for future operations, innovations, or market service development, statements regarding acquisitions, joint ventures, divestitures and other proposed or contemplated transactions (including but not limited to statements regarding the potential for future acquisitions and perceived benefits of acquisitions), statements of future economic performance, statements regarding legal proceedings and other loss contingencies (including but not limited to the timing and amount of costs incurred in connection with such proceedings), statements regarding market risk exposures, statements regarding the effects and/or interpretations of recently enacted or future health care laws and regulations, statements of the beliefs or assumptions underlying or relating to any of the foregoing statements, and other statements which are other than statements of historical fact, are considered to be "forward-looking statements."

Because they are forward-looking, such statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Health Management Associates, Inc.'s most recent Annual Report on Form 10-K, for the year ended December 31, 2011 and Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, including under the heading entitled "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of Health Management Associates, Inc.'s underlying beliefs or assumptions prove incorrect, actual results could vary materially from those currently anticipated. In addition, undue reliance should not be placed on Health Management Associates, Inc.'s forward-looking statements. Except as required by law, Health Management Associates, Inc. disclaims any obligation to update its risk factors or to publicly announce updates to the forward-looking statements contained in this press release to reflect new information, future events or other developments.